Melanocortin-pharmacology research domains for PT-141 with verifiable database links.
Where it appears
PT-141 appears across melanocortin-receptor pharmacology, GPCR-signaling and structure-activity research literature. As a tool agonist it is widely cited in studies mapping MC1R and MC4R behavior, and its approved-medicine status in some markets adds to its citation footprint.
How to survey the literature
Begin with the database links below, searching the full name Bremelanotide alongside melanocortin or MC4R to surface the most relevant primary studies for independent assessment.
Scope note
This material is supplied for research use only. Clinical information for the approved medicine pertains to regulated contexts elsewhere and is not part of this reference data.
Evidence limits and research safety
Research findings can differ by model, assay, purity, formulation, and study design. Published cell, biochemical, and pre-clinical observations do not establish human or veterinary safety, efficacy, dosing, or suitability. Researchers should review the applicable SDS, institutional safety procedures, waste requirements, and lot-specific documentation before handling any reference material.
Related research
Explore the peptide collection
Credible sources
- PubChem — Bremelanotide
- PubMed literature — Bremelanotide PT-141
- PubMed literature — melanocortin MC4R pharmacology